Results 191 to 195 of about 4,340 (195)

Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer

International Journal of Cancer, 2008
exaly  

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia

European Journal of Haematology, 2008
Peter Gimsing, Mads Hansen, Ib Jarle Christensen   +2 more
exaly  

LC–MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2013
Brian F Kiesel, Robert A Parise, Einārs Loza   +2 more
exaly  

Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF‐κB and Bim

British Journal of Haematology, 2011
Yun Dai, Xin-Yan Pei, Lora B Kramer
exaly  

Belinostat (Beleodaq) for peripheral T-Cell lymphoma.

The Medical letter on drugs and therapeutics, 2016
openaire   +1 more source